Surgical Management of Symptomatic Posterior Circulation Aneurysms
Sinir Sistemi Cerrahisi Dergisi · 2014
DOI: 10.5222/sscd.2014.095 ↗Kurz gefasst
Fachartikel in der Zeitschrift Sinir Sistemi Cerrahisi Dergisi, 2014. Verfasst von Mustafa Bozbuğa und 1 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Surgical treatment of posterior circulation aneurysms is more difficult than surgical treatment of anterior circulation aneurysms and poses a greater technical challenge for the practicing neurosurgeon. There are different surgical options available for the surgical treatment of posterior circulation aneurysms despite the use of the pterional approach to anterior circulation aneurysms. We present our surgical experiences with three cases of posterior circulation aneurysms. Three cases of posterior circulation aneurysms were treated by surgical clipping. We preferred pterional approach for posterior cerebral artery aneurysms, infratentorial supracerebellar approach for superior cerebellar aneurysm, and the combined lateral supracerebellar infratentorial retrosigmoid approach for vertebrobasilar junction aneurysm. The morbidity and mortality associated with open surgery for posterior circulation aneurysms are higher because of the location of the aneurysms within the posterior fossa. For neurosurgeons, the surgical treatment of posterior circulation aneurysms can be challenging.
Zitieren
APA
Bozbuğa, M., & Süslü, H. T. (2014). Surgical Management of Symptomatic Posterior Circulation Aneurysms. Sinir Sistemi Cerrahisi Dergisi. https://doi.org/10.5222/sscd.2014.095
Vancouver
Bozbuğa M, Süslü HT. Surgical Management of Symptomatic Posterior Circulation Aneurysms. Sinir Sistemi Cerrahisi Dergisi. 2014. doi:10.5222/sscd.2014.095
BibTeX
@article{Bozbua2014,
author = {Bozbuğa, Mustafa and Süslü, Hikmet Turan},
title = {Surgical Management of Symptomatic Posterior Circulation Aneurysms},
journal = {Sinir Sistemi Cerrahisi Dergisi},
year = {2014},
doi = {10.5222/sscd.2014.095}
}
EUVIMED